IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

TIMOTHY R KESSLER

Physician Assistants & Advanced Practice Nursing Providers Physician Assistant

NPI
1326215997
CMS profile
10430725
Location
GRAND BLANC, MI

General Payments · PY2021–2024

$4,237.05

  • Reported across 298 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$942.62

51 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Physician Assistant MI All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $653.64 48
Education $288.98 3

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Janssen Biotech, Inc. $211.22 4
NOVARTIS PHARMACEUTICALS CORPORATION $185.17 26
SANOFI-AVENTIS U.S. LLC $94.99 1
Boehringer Ingelheim Pharmaceuticals, Inc. $82.65 3
Regeneron Healthcare Solutions, Inc. $80.66 3
PFIZER INC. $70.03 4
ABBVIE INC. $64.35 3
Amgen Inc. $53.55 2
LEO Pharma Inc. $40.06 2
Galderma Laboratories, L.P. $36.69 2
GENZYME CORPORATION $23.25 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $1,201.89 85
PY2022 $1,190.85 95
PY2023 $901.69 67
PY2024 $942.62 51

Payment records · PY2024 (51)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $24.61 02/21/2024 Food and Beverage Undisputed 01/23/2026 1107456240 CMS
ABBVIE INC. $18.72 04/24/2024 Food and Beverage Undisputed 01/23/2026 1107456242 CMS
ABBVIE INC. $21.02 08/22/2024 Food and Beverage Undisputed 01/23/2026 1107456244 CMS
Amgen Inc. $29.35 02/22/2024 Food and Beverage Undisputed 01/23/2026 1117596870 CMS
Amgen Inc. $24.20 04/23/2024 Food and Beverage Undisputed 01/23/2026 1117596872 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $26.47 03/14/2024 Food and Beverage Undisputed 01/23/2026 1117964709 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $28.91 07/16/2024 Food and Beverage Undisputed 01/23/2026 1117964713 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $27.27 11/20/2024 Food and Beverage Undisputed 01/23/2026 1117964711 CMS
Galderma Laboratories, L.P. $19.53 09/09/2024 Food and Beverage Undisputed 01/23/2026 1145368671 CMS
Galderma Laboratories, L.P. $17.16 11/15/2024 Food and Beverage Undisputed 01/23/2026 1145368673 CMS
GENZYME CORPORATION $23.25 05/29/2024 Food and Beverage Undisputed 01/23/2026 1139697860 CMS
Janssen Biotech, Inc. $14.28 04/17/2024 Food and Beverage Undisputed 01/23/2026 1078746038 CMS
Janssen Biotech, Inc. $99.00 05/02/2024 Education Undisputed 01/23/2026 1078745468 CMS
Janssen Biotech, Inc. $2.95 05/29/2024 Food and Beverage Undisputed 01/23/2026 1078745970 CMS
Janssen Biotech, Inc. $94.99 12/10/2024 Education Undisputed 01/23/2026 1078745726 CMS
LEO Pharma Inc. $20.61 07/23/2024 Food and Beverage Undisputed 01/23/2026 1152674545 CMS
LEO Pharma Inc. $19.45 10/29/2024 Food and Beverage Undisputed 01/23/2026 1152674547 CMS
Novartis Pharmaceuticals Corporation $11.79 01/17/2024 Food and Beverage Undisputed 01/23/2026 1087020736 CMS
Novartis Pharmaceuticals Corporation $15.44 01/30/2024 Food and Beverage Undisputed 01/23/2026 1087020738 CMS
Novartis Pharmaceuticals Corporation $1.37 02/13/2024 Food and Beverage Undisputed 01/23/2026 1087020740 CMS
Novartis Pharmaceuticals Corporation $9.43 03/11/2024 Food and Beverage Undisputed 01/23/2026 1087020748 CMS
Novartis Pharmaceuticals Corporation $1.59 03/26/2024 Food and Beverage Undisputed 01/23/2026 1087020746 CMS
Novartis Pharmaceuticals Corporation $1.62 04/15/2024 Food and Beverage Undisputed 01/23/2026 1087020750 CMS
Novartis Pharmaceuticals Corporation $2.87 05/02/2024 Food and Beverage Undisputed 01/23/2026 1087020752 CMS
Novartis Pharmaceuticals Corporation $13.33 05/02/2024 Food and Beverage Undisputed 01/23/2026 1087020754 CMS
Novartis Pharmaceuticals Corporation $3.46 05/14/2024 Food and Beverage Undisputed 01/23/2026 1087020760 CMS
Novartis Pharmaceuticals Corporation $1.22 05/22/2024 Food and Beverage Undisputed 01/23/2026 1087020762 CMS
Novartis Pharmaceuticals Corporation $1.57 05/29/2024 Food and Beverage Undisputed 01/23/2026 1087020764 CMS
Novartis Pharmaceuticals Corporation $32.89 06/10/2024 Food and Beverage Undisputed 01/23/2026 1087020758 CMS
Novartis Pharmaceuticals Corporation $1.57 06/20/2024 Food and Beverage Undisputed 01/23/2026 1087020766 CMS
Novartis Pharmaceuticals Corporation $1.43 07/02/2024 Food and Beverage Undisputed 01/23/2026 1087020768 CMS
Novartis Pharmaceuticals Corporation $1.50 07/17/2024 Food and Beverage Undisputed 01/23/2026 1087020774 CMS
Novartis Pharmaceuticals Corporation $1.46 07/30/2024 Food and Beverage Undisputed 01/23/2026 1087020776 CMS
Novartis Pharmaceuticals Corporation $11.12 08/12/2024 Food and Beverage Undisputed 01/23/2026 1087020770 CMS
Novartis Pharmaceuticals Corporation $7.87 08/13/2024 Food and Beverage Undisputed 01/23/2026 1087020778 CMS
Novartis Pharmaceuticals Corporation $1.37 08/22/2024 Food and Beverage Undisputed 01/23/2026 1087020780 CMS
Novartis Pharmaceuticals Corporation $6.07 09/05/2024 Food and Beverage Undisputed 01/23/2026 1087020782 CMS
Novartis Pharmaceuticals Corporation $13.89 09/17/2024 Food and Beverage Undisputed 01/23/2026 1087020784 CMS
Novartis Pharmaceuticals Corporation $3.60 09/17/2024 Food and Beverage Undisputed 01/23/2026 1087020786 CMS
Novartis Pharmaceuticals Corporation $4.53 10/21/2024 Food and Beverage Undisputed 01/23/2026 1087020790 CMS
Novartis Pharmaceuticals Corporation $1.60 11/18/2024 Food and Beverage Undisputed 01/23/2026 1087020794 CMS
Novartis Pharmaceuticals Corporation $16.61 11/25/2024 Food and Beverage Undisputed 01/23/2026 1087020792 CMS
Novartis Pharmaceuticals Corporation $15.97 12/16/2024 Food and Beverage Undisputed 01/23/2026 1087020796 CMS
PFIZER INC. $15.33 04/23/2024 Food and Beverage Undisputed 01/23/2026 1131737168 CMS
PFIZER INC. $21.33 07/18/2024 Food and Beverage Undisputed 01/23/2026 1131767446 CMS
PFIZER INC. $19.25 08/13/2024 Food and Beverage Undisputed 01/23/2026 1131854435 CMS
PFIZER INC. $14.12 12/09/2024 Food and Beverage Undisputed 01/23/2026 1131170373 CMS
Regeneron Healthcare Solutions, Inc. $23.07 03/12/2024 Food and Beverage Undisputed 01/23/2026 1114325318 CMS
Regeneron Healthcare Solutions, Inc. $37.00 06/25/2024 Food and Beverage Undisputed 01/23/2026 1114325320 CMS
Regeneron Healthcare Solutions, Inc. $20.59 10/16/2024 Food and Beverage Undisputed 01/23/2026 1114325322 CMS
SANOFI-AVENTIS U.S. LLC $94.99 10/04/2024 Education Undisputed 01/23/2026 1139697920 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.